Biography and Research Information
OverviewAI-generated summary
Li Xia's research investigates molecular mechanisms underlying disease, with recent work focusing on the role of metabolic pathways and epigenetic modifications in cancer progression, specifically pancreatic ductal adenocarcinoma. Xia has also explored the impact of non-coding RNAs, such as circular RNAs, on inflammatory responses in skin conditions like atopic dermatitis and psoriasis, often examining these processes in the context of specific molecular pathways, including N6-methyladenosine modification. Further research interests include the cellular sensing of nutrient availability and its connection to cellular signaling pathways like mTOR. Additionally, Xia's work has touched upon the development and application of targeted radiotracers for cancer imaging and therapy, as well as the environmental impact of nanoplastics on cellular health. Xia has published 124 papers, with a total of 5,455 citations and an h-index of 15.
Metrics
- h-index: 15
- Publications: 123
- Citations: 5,527
Selected Publications
-
N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA (2025)
-
Germline mutagenicity of molnupiravir and its active form, β-d-N4-hydroxycytidine, in Caenorhabditis elegans evaluated using whole-genome sequencing (2025)
-
Genotoxicity of nanoparticles evaluated using the <i>in vitro</i> micronucleus assay, a review of recent data <sup>§</sup> (2025)
Collaboration Network
Top Collaborators
Ping Cai
Affiliated Hospital of Southwest Medical University (CN)
2 shared publications
- High Affinity and FAP-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake for FAP Inhibitors
- Improve the Biodistribution with Bulky and Lipophilic Modification Strategies on Lys-Urea-Glu-Based PSMA-Targeting Radiotracers
Sufan Tang
Southwest Medical University (CN)
2 shared publications
- High Affinity and FAP-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake for FAP Inhibitors
- Improve the Biodistribution with Bulky and Lipophilic Modification Strategies on Lys-Urea-Glu-Based PSMA-Targeting Radiotracers
Yinwen Wang
First Affiliated Hospital of Sichuan Medical University (CN)
2 shared publications
- High Affinity and FAP-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake for FAP Inhibitors
- Improve the Biodistribution with Bulky and Lipophilic Modification Strategies on Lys-Urea-Glu-Based PSMA-Targeting Radiotracers
Yue Feng
Affiliated Hospital of Southwest Medical University (CN)
2 shared publications
- High Affinity and FAP-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake for FAP Inhibitors
- Improve the Biodistribution with Bulky and Lipophilic Modification Strategies on Lys-Urea-Glu-Based PSMA-Targeting Radiotracers
Yue Chen
Affiliated Hospital of Southwest Medical University (CN)
2 shared publications
- High Affinity and FAP-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake for FAP Inhibitors
- Improve the Biodistribution with Bulky and Lipophilic Modification Strategies on Lys-Urea-Glu-Based PSMA-Targeting Radiotracers
Jian Yan
United States Food and Drug Administration (US)
2 shared publications
- Germline mutagenicity of molnupiravir and its active form, β-d-N4-hydroxycytidine, in Caenorhabditis elegans evaluated using whole-genome sequencing
- N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA
Wenqian Zhou
Wuhan University of Technology (CN)
1 shared publication
- Research on the Influence of the Trust of the Government in Different Order on the Environmental Performance Evaluation of the People s Government and the Intermediary Mechanism
Chang Yi
Wuhan University of Technology (CN)
1 shared publication
- Research on the Influence of the Trust of the Government in Different Order on the Environmental Performance Evaluation of the People s Government and the Intermediary Mechanism
Ying Lu
Ministry of Education (TH)
1 shared publication
- CD34 is a target for covalent EGFR inhibitors to eliminate stem/progenitor cells in acute and chronic myeloid leukemia
Lixue Yang
Shanghai Jiao Tong University (CN)
1 shared publication
- CD34 is a target for covalent EGFR inhibitors to eliminate stem/progenitor cells in acute and chronic myeloid leukemia
Hongchen Liu
Second Affiliated Hospital of Dalian Medical University (CN)
1 shared publication
- CD34 is a target for covalent EGFR inhibitors to eliminate stem/progenitor cells in acute and chronic myeloid leukemia
Yue Jiang
Second Affiliated Hospital of Dalian Medical University (CN)
1 shared publication
- CD34 is a target for covalent EGFR inhibitors to eliminate stem/progenitor cells in acute and chronic myeloid leukemia
Zhijie Kang
Second Affiliated Hospital of Dalian Medical University (CN)
1 shared publication
- CD34 is a target for covalent EGFR inhibitors to eliminate stem/progenitor cells in acute and chronic myeloid leukemia
Cheng-Tao Zhang
Second Affiliated Hospital of Dalian Medical University (CN)
1 shared publication
- CD34 is a target for covalent EGFR inhibitors to eliminate stem/progenitor cells in acute and chronic myeloid leukemia
Beibei Gao
Second Affiliated Hospital of Dalian Medical University (CN)
1 shared publication
- CD34 is a target for covalent EGFR inhibitors to eliminate stem/progenitor cells in acute and chronic myeloid leukemia
Similar Researchers
Based on overlapping research topics
Matthew J. Igoe
University of Arkansas at Fayetteville
Cancer-related molecular mechanisms research
Immune Response and Inflammation
Metabolism and Genetic Disorders
Jacob L. Edmondson
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Immune Response and Inflammation
Metabolism and Genetic Disorders
John Gillenwater
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Immune Response and Inflammation
Metabolism and Genetic Disorders
Gaven K. Smart
University of Arkansas at Fayetteville
Cancer-related molecular mechanisms research
Immune Response and Inflammation
Metabolism and Genetic Disorders
H.K. Wong
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Epigenetics and DNA Methylation
Immune Response and Inflammation
Yi Qin
Arkansas Agricultural Experiment Station
Cancer-related molecular mechanisms research
Immune Response and Inflammation
Nanoparticles: synthesis and applications